Gumen, Jonalyn .
HRN: 18-68-83 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/15/2024
CEFUROXIME 750MG (VIAL)
08/15/2024
08/22/2024
IVTT
570 MG
Q8HRS
PCAP-C
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes